Clinical Guidelines and Definitions for Weight Recurrence After Bariatric Surgery

Overview

Weight recurrence (WR) after metabolic and bariatric surgery (MBS) is common but inconsistently defined, complicating diagnosis and management. This review proposes standardized definitions for WR, partial response, and nonresponse, and summarizes current management strategies emphasizing a multidisciplinary approach.

Background

Metabolic and bariatric surgery is the most effective treatment for obesity, improving weight and comorbidities long-term. Patients typically reach their lowest weight within 24 months post-surgery, with half maintaining weight loss at five years. However, WR rates vary widely due to inconsistent definitions, and WR can negatively impact health and quality of life. Distinguishing WR from partial response and nonresponse is critical, as these represent different biological phenomena requiring tailored management.

Data Highlights

Key Findings

• Weight recurrence definitions vary widely, including nadir weight, percent total weight loss (TWL), and excess weight loss (EWL), with 45.4% of studies not defining WR at all.
• Partial response and nonresponse are often conflated with WR despite distinct pathophysiologies.
• Only 54% of studies discussed clinical management strategies, which differ by provider specialty.
• Dietitians emphasize behavioral and lifestyle modifications; surgeons favor multimodal approaches including pharmacotherapy and surgical revision.
• Few studies (2.5%) propose structured treatment algorithms, generally following a stepwise approach from lifestyle to pharmacologic to surgical interventions.
• Significant knowledge gaps exist due to limited high-quality evidence, small samples, lack of standardized definitions, and short follow-up.

Clinical Implications

Clinicians should adopt standardized definitions of WR, partial response, and nonresponse to improve diagnosis and treatment consistency. A multidisciplinary approach is recommended, beginning with behavioral and dietary interventions, progressing to pharmacotherapy, and considering surgical revision when appropriate. Awareness of the chronic, relapsing nature of obesity is essential to avoid stigmatizing terminology and to guide long-term management.

Conclusion

Standardizing definitions and treatment frameworks for weight recurrence and related responses after bariatric surgery is critical to optimize patient outcomes. Coordinated, evidence-based guidelines will support timely identification and tailored management of these complex conditions.

References

1. ASMBS POWER Task Force 2023 -- Clinical Guidelines and Definitions for Addressing Weight Recurrence After MBS